Skip to main content

SM Choi

First name:
SM
Last name:
Choi
Kwon, J., Kang, M., Kim, S., Choi, S., Kim, H., Min, W., & Lee, D. (1969). A case of pseudomembranous colitis after voriconazole therapy. Yonsei Medical Journal, 52(5), 863-5. https://doi.org/10.3349/ymj.2011.52.5.863 (Original work published)
Kim, Y., Lee, W., Choi, S., Seo, Y., Ahn, B., Kim, S., & Kim, S. (1969). DA6034 promotes gastric epithelial cell migration and wound-healing through the mTOR pathway. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/j.1440-1746.2011.06873.x (Original work published)
Kim, S., Yim, D., Choi, S., Kwon, J., Han, S., Lee, D., … Yoo, J. (1969). Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases. https://doi.org/10.1016/j.ijid.2011.06.004 (Original work published)
Jiang, J., Yang, E., Baek, M., Kim, S., Lee, S., & Choi, S. (2011). Anti-inflammatory effects of electroacupuncture in the respiratory system of a symptomatic amyotrophic lateral sclerosis animal model. Neuro-Degenerative Diseases, 8(6), 504-14. https://doi.org/10.1159/000327911 (Original work published 2011)
Park, S., Choi, S., Lee, D., Kim, J., Choi, J., Kim, S., … Yoo, J. (1969). Emergence of Extended-Spectrum β-Lactamase-Producing Escherichia coli as a Cause of Community-Onset Bacteremia in South Korea: Risk Factors and Clinical Outcomes. Microbial Drug Resistance (Larchmont, N.Y.). https://doi.org/10.1089/mdr.2011.0072 (Original work published)